186 related articles for article (PubMed ID: 16789745)
21. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
Al-Saadi MS; Faidallah HM; Rostom SA
Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anti-cancer activity of C-ring-functionalized prodigiosin analogues.
Regourd J; Ali AA; Thompson A
J Med Chem; 2007 Apr; 50(7):1528-36. PubMed ID: 17348639
[TBL] [Abstract][Full Text] [Related]
24. Binding site of brefeldin A at the interface between the small G protein ADP-ribosylation factor 1 (ARF1) and the nucleotide-exchange factor Sec7 domain.
Robineau S; Chabre M; Antonny B
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9913-8. PubMed ID: 10954741
[TBL] [Abstract][Full Text] [Related]
25. 1-Butanol targets the Golgi apparatus in tobacco BY-2 cells, but in a different way to Brefeldin A.
Langhans M; Robinson DG
J Exp Bot; 2007; 58(12):3439-47. PubMed ID: 17977851
[TBL] [Abstract][Full Text] [Related]
26. An Arf1 GTPase mutant with different responses to GEF inhibitors.
Flisiak S; Zeeh JC; Guibert B; Cherfils J; Zeghouf M
Biochem Biophys Res Commun; 2008 Dec; 377(1):156-60. PubMed ID: 18834864
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of S-dialkylarsino-3-mercapto-1,2-propanediols and evaluation of their anticancer activity.
Gao M; Tan S; Chen Y; Zingaro RA
Bioorg Med Chem; 2007 Apr; 15(7):2660-6. PubMed ID: 17287125
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6-trifluoromethyl-3-pyridinecarboxylic acids.
Onnis V; Cocco MT; Lilliu V; Congiu C
Bioorg Med Chem; 2008 Mar; 16(5):2367-78. PubMed ID: 18065230
[TBL] [Abstract][Full Text] [Related]
29. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor activity of aromatic camptothecin esters.
Cao Z; Mendoza J; Dejesus A; Vardeman D; Giovanella B
Int J Mol Med; 2008 Apr; 21(4):477-87. PubMed ID: 18360694
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivatives.
Amin KM; El-Zahar MI; Anwar MM; Kamel MM; Mohamed MH
Acta Pol Pharm; 2009; 66(3):279-91. PubMed ID: 19645328
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of interaction between ADP-ribosylation factor-1 (Arf1) and the Sec7 domain of Arno guanine nucleotide exchange factor, modulation by allosteric factors, and the uncompetitive inhibitor brefeldin A.
Rouhana J; Padilla A; Estaran S; Bakari S; Delbecq S; Boublik Y; Chopineau J; Pugnière M; Chavanieu A
J Biol Chem; 2013 Feb; 288(7):4659-72. PubMed ID: 23255605
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities.
Argade AB; Devraj R; Vroman JA; Haugwitz RD; Hollingshead M; Cushman M
J Med Chem; 1998 Aug; 41(18):3337-46. PubMed ID: 9719586
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
Xie F; Zhao H; Zhao L; Lou L; Hu Y
Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
[TBL] [Abstract][Full Text] [Related]
37. Design and development of water-soluble curcumin conjugates as potential anticancer agents.
Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA
J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470
[TBL] [Abstract][Full Text] [Related]
38. In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. I. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl ureas.
Dulude H; Salvador R; Gallant G
Anticancer Res; 1995; 15(3):847-52. PubMed ID: 7645969
[TBL] [Abstract][Full Text] [Related]
39. Novel thiosemicarbazone derivatives as potential antitumor agents: Synthesis, physicochemical and structural properties, DNA interactions and antiproliferative activity.
Dilović I; Rubcić M; Vrdoljak V; Kraljević Pavelić S; Kralj M; Piantanida I; Cindrić M
Bioorg Med Chem; 2008 May; 16(9):5189-98. PubMed ID: 18358728
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives.
Stanchev S; Momekov G; Jensen F; Manolov I
Eur J Med Chem; 2008 Apr; 43(4):694-706. PubMed ID: 17614164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
